Details for New Drug Application (NDA): 208158
✉ Email this page to a colleague
NDA 208158 describes ALAWAY, which is a drug marketed by Bausch And Lomb and Bausch And Lomb Inc and is included in two NDAs. It is available from thirteen suppliers. Additional details are available on the ALAWAY profile page.
The generic ingredient in ALAWAY is ketotifen fumarate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ketotifen fumarate profile page.
The generic ingredient in ALAWAY is ketotifen fumarate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ketotifen fumarate profile page.
Summary for 208158
| Tradename: | ALAWAY |
| Applicant: | Bausch And Lomb Inc |
| Ingredient: | ketotifen fumarate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 208158
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.025% BASE | ||||
| Approval Date: | Sep 24, 2020 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
